UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Behavioral: Survey
Behavioral: mHealth app

First Posted Date: 2024-04-11

Last Posted Date: 2024-04-17

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 80

Registration Number: NCT06361056

Locations: 🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

Phase 1

Recruiting

Conditions: Relapse
Resistant Cancer
Breast Cancer
Triple Negative Breast Cancer

Interventions: Biological: iC9-CAR.B7-H3 T Cell Therapy
Drug: cyclophosphamide
Drug: fludarabine

First Posted Date: 2024-04-04

Last Posted Date: 2024-10-26

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 42

Registration Number: NCT06347068

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

Phase 2

Not yet recruiting

Conditions: Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Autologous Stem Cell Transplantation

Interventions: Biological: Daratumumab
Drug: Lenalidomide
Drug: Bortezomib
Drug: Dexamethasone

First Posted Date: 2024-04-04

Last Posted Date: 2025-01-03

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 39

Registration Number: NCT06348147

Locations: 🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

UNC Metastatic Cancer Radiation Therapy Registry

Recruiting

Conditions: Metastatic Cancer
Cancer

Interventions: Radiation: Radiation therapy

First Posted Date: 2024-03-12

Last Posted Date: 2024-04-26

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 2000

Registration Number: NCT06306924

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia

Not Applicable

Not yet recruiting

Conditions: Head and Neck Cancer
Oropharynx Cancer
Xerostomia

Interventions: Radiation: experimental radiotherapy
Radiation: standard radiotherapy

First Posted Date: 2024-02-26

Last Posted Date: 2025-01-03

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 98

Registration Number: NCT06276946

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina, United States

Promoting CT Engagement for Pancreatic Cancer With App

Not Applicable

Recruiting

Conditions: Pancreas Cancer

Interventions: Behavioral: feedback
Behavioral: semistructured interviews

First Posted Date: 2024-02-09

Last Posted Date: 2025-01-03

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 26

Registration Number: NCT06252545

Locations: 🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
🇺🇸
Medical College Of Wisconsin, Milwaukee, Wisconsin, United States

Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya

Phase 1

Recruiting

Conditions: Cervix Neoplasm
Precancerous Conditions
Cervix Cancer
Cervical Precancer

Interventions: Drug: Artesunate pessary
Procedure: Colposcopy

First Posted Date: 2023-12-11

Last Posted Date: 2024-04-09

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 18

Registration Number: NCT06165614

Locations: 🇰🇪
Lumumba Sub-County Hospital, Kisumu, Kenya

Autologous CAR-T Cells Targeting B7-H3 in PDAC

Phase 1

Recruiting

Conditions: Relapse
Resistant Cancer
Pancreas Cancer

Interventions: Biological: iC9-CAR.B7-H3 T cell infusion

First Posted Date: 2023-12-06

Last Posted Date: 2024-10-24

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 27

Registration Number: NCT06158139

Locations: 🇺🇸
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

Phase 1

Recruiting

Conditions: Recurrent
Refractory Cancer
Head and Neck Cancer
Relapse

Interventions: Drug: Cyclophosphamide
Drug: Fludarabine
Biological: Cell Therapy

First Posted Date: 2023-10-23

Last Posted Date: 2024-11-14

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 33

Registration Number: NCT06096038

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States

GRID Therapy for Extremity Soft Tissue Sarcoma

Not Applicable

Recruiting

Conditions: Sarcoma

Interventions: Radiation: GRID therapy

First Posted Date: 2023-10-10

Last Posted Date: 2024-10-14

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT06073067

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy